John F. Milligan
2016
In 2016, John F. Milligan earned a total compensation of $13.9M as President and Chief Executive Officer at Gilead Sciences, a 68% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,610,000 |
|---|---|
| Option Awards | $5,500,077 |
| Salary | $1,465,385 |
| Stock Awards | $4,349,750 |
| Other | $10,000 |
| Total | $13,935,212 |
Milligan received $5.5M in option awards, accounting for 39% of the total pay in 2016.
Milligan also received $2.6M in non-equity incentive plan, $1.5M in salary, $4.3M in stock awards and $10K in other compensation.
Rankings
In 2016, John F. Milligan's compensation ranked 272nd out of 14,075 executives tracked by ExecPay. In other words, Milligan earned more than 98.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 272 out of 14,075 | 98th |
Division Manufacturing | 87 out of 5,488 | 98th |
Major group Chemicals And Allied Products | 23 out of 1,900 | 99th |
Industry group Drugs | 18 out of 1,543 | 99th |
Industry Biological Products, Except Diagnostic Substances | 3 out of 287 | 99th |
Source: SEC filing on March 26, 2018.
Milligan's colleagues
We found four more compensation records of executives who worked with John F. Milligan at Gilead Sciences in 2016.